Analysis Overview for Lung Adenocarcinoma: 2012_11_15
Maintained by TCGA GDAC Team (Broad Institute/Dana-Farber Cancer Institute/Harvard Medical School)


Unique Tumor Sample Counts

TumorBCRClinicalCNLowPMethylationmRNAmRNAseqmiRmiRseqRPPAMAF
LUAD4392943580432323550366237229

Download run results with firehose_get version 0.3.8

Download command: firehose_get   awg_luad   2012_11_15

Task Dashboard
Overview
Introduction

This is the analysis overview for Firehose run "15 November 2012" in support of the LUAD analysis working group.

Summary

Note: These results are offered to the community as an additional reference point, enabling a wide range of cancer biologists, clinical investigators, and genome and computational scientists to easily incorporate TCGA into the backdrop of ongoing research. While every effort is made to ensure that Firehose input data and algorithms are of the highest possible quality, these analyses have not been reviewed by domain experts.

Results

  • Sequence and Copy Number Analyses

    • Copy number analysis (GISTIC2)
      View Report | There were 230 tumor samples used in this analysis: 28 significant arm-level results, 27 significant focal amplifications, and 40 significant focal deletions were found.

    • Mutation Analysis (MutSig v2.0)
      View Report | 

    • Mutation Analysis (MutSig vS2N)
      View Report | 

  • Clustering Analyses

    • Clustering of copy number data: consensus NMF
      View Report | The most robust consensus NMF clustering of 230 samples using the 67 copy number focal regions was identified for k = 3 clusters. We computed the clustering for k = 2 to k = 8 and used the cophenetic correlation coefficient to determine the best solution.

    • Clustering of Methylation: consensus NMF
      View Report | The 3655 most variable methylated genes were selected based on variation. The variation cutoff are set for each tumor type empirically by fitting a bimodal distriution. For genes with multiple methylation probes, we chose the most variable one to represent the gene. Consensus NMF clustering of 181 samples and 3655 genes identified 4 subtypes with the stability of the clustering increasing for k = 2 to k = 8 and the average silhouette width calculation for selecting the robust clusters.

    • Clustering of mRNA expression: consensus NMF
      View Report | The most robust consensus NMF clustering of 23 samples using the 1500 most variable genes was identified for k = 2 clusters. We computed the clustering for k = 2 to k = 8 and used the cophenetic correlation coefficient to determine the best solution.

    • Clustering of mRNA expression: consensus hierarchical
      View Report | The 1500 most variable genes were selected. Consensus average linkage hierarchical clustering of 23 samples and 1500 genes identified 5 subtypes with the stability of the clustering increasing for k = 2 to k = 8 and the average silhouette width calculation for selecting the robust clusters.

    • Clustering of mRNAseq gene expression: consensus NMF
      View Report | The most robust consensus NMF clustering of 230 samples using the 1500 most variable genes was identified for k = 3 clusters. We computed the clustering for k = 2 to k = 8 and used the cophenetic correlation coefficient to determine the best solution.

    • Clustering of mRNAseq gene expression: consensus hierarchical
      View Report | The 1500 most variable genes were selected. Consensus average linkage hierarchical clustering of 230 samples and 1500 genes identified 3 subtypes with the stability of the clustering increasing for k = 2 to k = 8 and the average silhouette width calculation for selecting the robust clusters.

    • Clustering of miRseq expression: consensus NMF
      View Report | We filtered the data to 150 most variable miRs. Consensus NMF clustering of 230 samples and 150 miRs identified 3 subtypes with the stability of the clustering increasing for k = 2 to k = 8 and the average silhouette width calculation for selecting the robust clusters.

    • Clustering of miRseq expression: consensus hierarchical
      View Report | We filtered the data to 150 most variable miRs. Consensus average linkage hierarchical clustering of 230 samples and 150 miRs identified 3 subtypes with the stability of the clustering increasing for k = 2 to k = 8 and the average silhouette width calculation for selecting the robust clusters.

  • Correlation Analyses

    • Correlation between copy number variations of arm-level result and selected clinical features
      View Report | Testing the association between copy number variation 78 arm-level results and 15 clinical features across 223 patients, no significant finding detected with Q value < 0.25.

    • Correlation between copy number variation genes and selected clinical features
      View Report | Testing the association between copy number variation of 67 peak regions and 15 clinical features across 223 patients, one significant finding detected with Q value < 0.25.

    • Correlation between gene methylation status and clinical features
      View Report | Testing the association between 17306 genes and 15 clinical features across 173 samples, statistically thresholded by Q value < 0.05, 9 clinical features related to at least one genes.

    • Correlation between molecular cancer subtypes and selected clinical features
      View Report | Testing the association between subtypes identified by 8 different clustering approaches and 15 clinical features across 223 patients, 19 significant findings detected with P value < 0.05.

    • Correlation between gene mutation status and selected clinical features
      View Report | Testing the association between mutation status of 198 genes and 15 clinical features across 129 patients, 11 significant findings detected with Q value < 0.25.

    • Correlation between mRNA expression and clinical features
      View Report | Testing the association between 17814 genes and 11 clinical features across 23 samples, statistically thresholded by Q value < 0.05, no clinical feature related to at least one genes.

    • Correlation between mRNAseq expression and clinical features
      View Report | Testing the association between 18249 genes and 15 clinical features across 223 samples, statistically thresholded by Q value < 0.05, 12 clinical features related to at least one genes.

    • Correlation between miRseq expression and clinical features
      View Report | Testing the association between 539 genes and 15 clinical features across 223 samples, statistically thresholded by Q value < 0.05, 4 clinical features related to at least one genes.

    • Correlations between copy number and mRNA expression
      View Report | The correlation coefficients in 10, 20, 30, 40, 50, 60, 70, 80, 90 percentiles are -0.15826, -0.02956, 0.06126, 0.1488, 0.2307, 0.30802, 0.3932, 0.4804, 0.5865, respectively.

    • Correlations between copy number and mRNAseq expression
      View Report | The correlation coefficients in 10, 20, 30, 40, 50, 60, 70, 80, 90 percentiles are 1025.9, 1750, 2347, 2904, 3498.5, 4133, 4764, 5467.2, 6246.1, respectively.

    • Correlation between mRNA expression and DNA methylation
      View Report | The top 25 correlated methylation probes per gene are displayed. Total number of matched samples = 181. Number of gene expression samples = 230. Number of methylation samples = 181.

  • Other Analyses

    • Preprocessing of clinical data
      View Report | Clinical data for tier 1 clinical variables are generated.

    • Association of mutation, copy number alteration, and subtype markers with pathways
      View Report | There are 114 genes with significant mutation (Q value <= 0.1) and 540 genes with significant copy number alteration (Q value <= 0.25). The identified marker genes (Q value <= 0.01 or within top 2000) are 18 for subtype 1. Pathways significantly enriched with these genes (Q value <= 0.01) are identified :

    • PARADIGM pathway analysis of mRNA expression data
      View Report | There were 24 significant pathways identified in this analysis.

    • PARADIGM pathway analysis of mRNA expression and copy number data
      View Report | There were 18 significant pathways identified in this analysis.

Methods & Data
Input

  • Run Prefix = awg_luad__2012_11_15

  • Summary Report Date = Tue Nov 20 17:12:01 2012

  • Protection = FALSE

Copyright © 2012 Broad Institute TCGA GDAC as part of the TCGA Research Network. All rights reserved.
Made with Nozzle